Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Finazzi

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Internal and Emergency Medicine|June 26, 2008
Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? NoGuido Finazzi
Blood|October 28, 2017
Ruxolitinib in ET: not all MPN are equalGuido Finazzi
Cancer Treatment and Research|February 21, 2008
Essential thrombocythemiaGuido Finazzi
Seminars in Thrombosis and Hemostasis|May 5, 2006
Risk stratification, staging, and treatment of patients with polycythemia vera: Italian and European collaboration on low-dose aspirin in polycythemia dataGuido Finazzi
European Journal of Haematology. Supplementum|August 31, 2007
Unanswered questions in polycythaemia veraGuido Finazzi
Haematologica|February 12, 2002
Rituximab in autoimmune cytopenias: for which patients?Guido Finazzi
Pathologie-Biologie|June 26, 2004
A prospective analysis of thrombotic events in the European collaboration study on low-dose aspirin in polycythemia (ECLAP)Guido Finazzi,
Current Hematology Reports|August 7, 2003
Treatment indications and choice of a platelet-lowering agent in essential thrombocythemiaTiziano Barbui, Guido Finazzi
Cancer Journal (Sudbury, Mass.)|November 23, 2007
Expertise-based management in essential thrombocythemia and polycythemia veraGuido Finazzi, Tiziano Barbui
The New England Journal of Medicine|July 8, 2005
When and how to treat essential thrombocythemiaTiziano Barbui, Guido Finazzi
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Internal and Emergency Medicine|June 26, 2008
Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? NoGuido Finazzi
Blood|October 28, 2017
Ruxolitinib in ET: not all MPN are equalGuido Finazzi
Cancer Treatment and Research|February 21, 2008
Essential thrombocythemiaGuido Finazzi
Seminars in Thrombosis and Hemostasis|May 5, 2006
Risk stratification, staging, and treatment of patients with polycythemia vera: Italian and European collaboration on low-dose aspirin in polycythemia dataGuido Finazzi
European Journal of Haematology. Supplementum|August 31, 2007
Unanswered questions in polycythaemia veraGuido Finazzi
Haematologica|February 12, 2002
Rituximab in autoimmune cytopenias: for which patients?Guido Finazzi
Pathologie-Biologie|June 26, 2004
A prospective analysis of thrombotic events in the European collaboration study on low-dose aspirin in polycythemia (ECLAP)Guido Finazzi,
Current Hematology Reports|August 7, 2003
Treatment indications and choice of a platelet-lowering agent in essential thrombocythemiaTiziano Barbui, Guido Finazzi
Cancer Journal (Sudbury, Mass.)|November 23, 2007
Expertise-based management in essential thrombocythemia and polycythemia veraGuido Finazzi, Tiziano Barbui
The New England Journal of Medicine|July 8, 2005
When and how to treat essential thrombocythemiaTiziano Barbui, Guido Finazzi
Pageof 13